When you go to “COOKIES INCL. ALLOW US SERVICES” click, you agree to the storage of cookies on your device to improve website navigation, analyze site usage, and support our marketing efforts. For more information, see our Privacy statement.

21.9.2023

DecoMed and Haemo Pharma present BRAXON® Fast in a new collaboration

We are very pleased to announce our cooperation with DecoMed. Our goal is to establish BRAXON® Fast on the Austrian market.

DecoMed and Haemo Pharma are presenting the BRAXON® Fast Implant, a product for breast reconstruction, as part of their new collaboration. The image shows the implant against a dark background.

Braxon Fast is the world's first preformed three-dimensional acellular dermal matrix (ADM) developed specifically for prepectoral breast reconstruction.

BRAXON® Fast, designed and patented by DecoMed, completely envelops the breast implant. This advanced ADM is characterized by ADIPOMATRIX® Collagen cover, which minimizes the foreign body response and prevents the onset of fibrotic reactions, even in the case of post-operative radiotherapy.

BRAXON® Fast is one of the most investigated processes worldwide. More than 60 international scientific studies confirm the success of the product in a wide variety of clinical scenarios.

To the BRAXON® Fast product page

Für weitere Informationen kontaktieren Sie bitte:

More posts

Product Presentation

Stem cell therapy for degenerative joint diseases

In an Ö24 interview, Prof. Dr. Zimpfer provides insights into stem cell therapy and new approaches .
Sponsoring

Lotteries Sporthilfe Gala 2024: A Celebration of Austrian Sports Talent

Outstanding local athletes were honored at the 28th LOTTERIES Sports Aid Gala in the Wiener Stadthalle.
Sponsoring

Haemo Pharma & WINBACK: Live at the Erste Bank Open 2024!

From 19-27. 10, the best tennis players will fight at the Erste Bank Open and we are proud to be an official sponsor.

Make evidence-based decisions

Learn more about our scientifically researched products. Please feel free to contact us for further information.